Stock ICU SEASTAR MEDICAL HOLDING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
0.405 USD -0.17% Intraday chart for SeaStar Medical Holding Corporation +18.59% -8.52%
04-30 SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure CI
04-16 SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
AQ
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
SeaStar Medical : Non-Reliance on Previously Issued Financial Report - Form 8-K
PU
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
AQ
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
AQ
Seastar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
CI
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
AQ
SeaStar Medical : Investor Presentation March
PU
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
AQ
SeaStar Medical Receives FDA Approval for Pediatric Kidney Treatment Device
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ICU Stock
  4. News SeaStar Medical Holding Corporation